Laddar...
When combination therapy isn’t working: Emerging therapies for the management of inflammatory bowel disease
Although antagonists of tumor necrosis factor have resulted in major therapeutic benefits in inflammatory bowel disease, the magnitude and durability of response are variable. Similar to previously available drugs such as 5-aminosalicylates and immunomodulators, the therapeutic effect is not univers...
Sparad:
| Huvudupphovsmän: | , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Baishideng Publishing Group Co., Limited
2014
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3921498/ https://ncbi.nlm.nih.gov/pubmed/24574790 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i5.1139 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|